Bio Essence Corporation
BIOE
$0.215
-$0.0201-8.55%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 312.60K | 333.60K | 551.50K | 892.80K | 591.60K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 312.60K | 333.60K | 551.50K | 892.80K | 591.60K |
| Cost of Revenue | 55.00K | 136.80K | 274.20K | 274.20K | 106.40K |
| Gross Profit | 257.70K | 196.90K | 277.40K | 277.40K | 143.90K |
| SG&A Expenses | 911.80K | 1.05M | 1.19M | 1.07M | 678.40K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 49.30K | 49.30K | -- | -- | -- |
| Total Operating Expenses | 1.02M | 1.24M | 1.47M | 1.34M | 784.60K |
| Operating Income | -703.40K | -904.10K | -916.50K | -789.00K | -534.30K |
| Income Before Tax | -1.72M | -833.60K | -900.00K | -800.10K | -551.30K |
| Income Tax Expenses | 0.00 | 0.00 | 2.40K | 2.40K | 2.50K |
| Earnings from Continuing Operations | -1.72 | -0.83 | -0.90 | -0.80 | -0.55 |
| Earnings from Discontinued Operations | 243.40K | 243.40K | 243.40K | -169.30K | -155.80K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.48M | -590.30K | -659.10K | -971.80K | -991.30K |
| EBIT | -703.40K | -904.10K | -916.50K | -789.00K | -534.30K |
| EBITDA | -720.20K | -904.60K | -901.10K | -771.60K | -522.50K |
| EPS Basic | -0.04 | -0.02 | -0.02 | -0.03 | -0.03 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.02 | -0.01 | -0.01 |
| EPS Diluted | -0.04 | -0.02 | -0.02 | -0.03 | -0.03 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.02 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 149.98M | 149.98M | 146.68M | 141.68M | 138.74M |
| Average Diluted Shares Outstanding | 149.98M | 149.98M | 146.68M | 141.68M | 138.74M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
